Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Leukemia, Myelogenous, Chronic, BCR-ABL Positive × Methotrexate × 30 days × Clear all

Sponsor

Conditions

Burkitt Lymphoma 11 Precursor Cell Lymphoblastic Leukemia-Lymphoma 9 Leukemia, Biphenotypic, Acute 5 Lymphoma 3 Leukemia, Myeloid, Acute 3 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 2 Osteosarcoma 2 Neoplasm Metastasis 2 Myelodysplastic Syndromes 2 Urinary Bladder Neoplasms 1 Shwachman-Diamond Syndrome 1 Rhabdoid Tumor 1 Renal Pelvis and Ureter Urothelial Carcinoma 1 Recurrence 1 Primary Myelofibrosis 1 Myeloproliferative Disorders 1 Myelodysplastic-Myeloproliferative Diseases 1 Multiple Myeloma 1 Meningeal Neoplasms 1 Leukemia, Myelomonocytic, Juvenile 1 Leukemia, Monocytic, Acute 1 Leukemia, Lymphoid 1 Leukemia 1 Hydatidiform Mole 1 Hemoglobinuria, Paroxysmal 1 Gestational Trophoblastic Disease 1 Down Syndrome 1 Congenital amegakaryocytic thrombocytopenia 1 Breast Neoplasms 1

Interventions

Cyclophosphamide 7 fludarabine phosphate 6 fludarabine 6 Whole-Body Irradiation 5 Mycophenolic Acid 4 asciminib 3 Mesna 3 Melphalan 3 Imatinib Mesylate 3 Granulocyte Colony-Stimulating Factor 3 Filgrastim 3 Dasatinib 3 nilotinib 2 bosutinib 2 Tacrolimus 2 Stem Cell Transplantation 2 Cyclosporine 2 Busulfan 2 Bone Marrow Transplantation 2 venetoclax 1 treosulfan 1 thymoglobulin 1 ponatinib 1 blinatumomab 1 aldesleukin 1 Thiotepa 1 Succimer 1 Peripheral Blood Stem Cell Transplantation 1 Pentetic Acid 1 Patient Reported Outcome Measures 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡